Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate

F. Khanim, N. Davies, P. Veliça, R. Hayden, J. Ride, C. Pararasa, M.G. Chong, U. Gunther, N. Veerapen, P. Winn, R. Farmer, E. Trivier, L. Rigoreau, M. Drayson, C. Bunce*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate'. Together they form a unique fingerprint.

Medicine & Life Sciences